Truveta

Truveta is a health data and analytics company on a mission to save lives with data. The company aggregates and analyzes electronic health record (EHR) data from more than 130 million patients — including clinical notes and images — linked with closed claims data covering 200 million patients, creating one of the most representative, complete, and timely patient journey datasets available. Truveta serves leading life science, public health, and healthcare organizations, providing regulatory-grade safety and effectiveness data capable of replacing traditional trials and registries.

Truveta is built on a growing collective of 30 health systems united by a shared mission. By combining real-world data, powerful analytics, and the proprietary Truveta Language Model, the platform enables customers to accelerate therapy adoption, advance patient care, and drive meaningful improvements across the healthcare ecosystem.

Core Use Cases and Solutions

• Safety: Supports post-market surveillance and pharmacovigilance by leveraging real-world EHR data to monitor therapy safety at scale.
• Health Economics and Outcomes Research (HEOR): Enables organizations to generate evidence on the clinical and economic value of therapies using comprehensive patient journey data.
• Clinical Trials: Helps optimize trial design, identify eligible patient populations, and supplement or replace traditional trial and registry approaches with real-world evidence.
• Research and Development (R&D): Supports drug discovery and therapy development through access to large-scale, diverse genotypic and phenotypic data, with the goal of transforming how diseases are prevented, diagnosed, and cured.
• Close Care Gaps: Empowers healthcare organizations to identify and address disparities in care quality and patient access across diverse populations and demographics.

Data and Platform Capabilities

• EHR data from more than 130 million patients, inclusive of structured data, clinical notes, and medical images.
• Linked with closed claims data covering 200 million patients for a longitudinal, comprehensive view of the patient journey.
• The Truveta Language Model enables advanced natural language processing of unstructured clinical data, unlocking insights from physician notes and other free-text sources.
• Aims to create the largest and most diverse database of genotypic and phenotypic information ever assembled to support drug discovery and clinical research.
• Data is de-identified and designed to be nationally representative, reflecting the full diversity of the U.S. patient population.

Network, Customers, and Notable Recognition

• Truveta is a collective of 30 health systems contributing data and sharing in the mission of improving patient outcomes through data-driven insights.
• Trusted by leading organizations including Boston Scientific, which uses Truveta to gather insights across a breadth of devices and disease states and to address healthcare access disparities across patient populations and demographics.
• Backed by prominent healthcare leaders, including Rod Hochman, MD, CEO Emeritus of Providence and Chair of the Truveta Board of Directors.
• Research and insights from Truveta have been featured in major media outlets, covering topics such as respiratory illness trends, mental health, blood pressure monitoring during pregnancy, and pandemic impacts on child development.

Truveta's combination of scale, diversity, and analytical depth positions it as a foundational resource for life sciences companies, public health agencies, and health systems seeking to generate real-world evidence, improve care quality, and ultimately save lives through the power of data.